Skip to content

Clinical trials

Withdrawn Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Withdrawn Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20073
20111
20142
20171
20182
20202
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Roswell Park Cancer Institute2
Alliance for Clinical Trials in Oncology1
Barbara Ann Karmanos Cancer Institute1
Fondation Hôpital Saint-Joseph1
Fox Chase Cancer Center1
H. Lee Moffitt Cancer Center and Research Institute1
Intima Bioscience, Inc.1
M.D. Anderson Cancer Center1
Royal Marsden NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung17
Carcinoma, Non-Small-Cell Lung15
Lung Neoplasms11
Adenocarcinoma, Bronchiolo-Alveolar3
Neoplasm Metastasis2
Adenocarcinoma1
Carcinoma1
Colorectal Neoplasms1
Lung Diseases1
Neoplasm, Residual1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.